Oceanside, CA, United States of America

Xiufeng Sun

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kura Oncology, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiufeng Sun. Retrieved from https://idiyas.com/inventor/xiufeng-sun-0by7729k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiufeng Sun: Innovator in Pharmaceutical Compounds

Introduction

Xiufeng Sun is a notable inventor based in Oceanside, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of macrocyclic compounds. Her work is crucial in advancing treatments for cancer.

Latest Patents

Xiufeng Sun holds 1 patent titled "Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same." This patent focuses on solid forms of Compound 1, including pharmaceutically acceptable forms and salts. The disclosure outlines pharmaceutical compositions and methods for treating cancer that depend on a farnesylated protein.

Career Highlights

She is currently employed at Kura Oncology, Inc., where she continues to innovate in the pharmaceutical sector. Her research and development efforts are aimed at improving cancer treatment options.

Collaborations

One of her notable coworkers is Kenneth K Liu, with whom she collaborates on various projects within the company.

Conclusion

Xiufeng Sun's contributions to pharmaceutical innovations highlight her role as a key inventor in the fight against cancer. Her work exemplifies the importance of research and development in creating effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…